Navigation Links
Over 55 Industry Experts Expected to Attend CPhI Worldwide's Pre-Connect Conference - the Pharma Industry's Leading Global Event

LONDON, July 17, 2013 /PRNewswire/ --

The global pharmaceutical industry is facing many challenges and uncertainties as companies strive to align their businesses with the key trends shaping the global marketplace. Revenues are coming under increasing pressure as a consequence of pricing controls caused by healthcare reforms and austerity measures, increased competition, and challenges in bringing new drugs and other products to market.

So, what are the most important decisions senior management will need to make to respond to these pressures? By offering information and insight through rigorous analysis of global and regional trends - from sourcing APIs to advancing drug delivery systems - we want to enable business development, manufacturing and partnering processes to realise their full potential. We do this by engaging senior pharmaceutical executives to speak on the latest hot topics, which in turn facilitates discussion and networking between peers of industry, solution providers and key decision makers alike.

This year, in conjunction with the CPhI Worldwide Exhibition, the 5th Annual Pre-Connect Conference will be taking place on 21 October at Messe Frankfurt, Germany. With 6 topical modules run across 3 parallel streams, 26 discussion themes, over 55 international industry experts and 180 companies attending, CPhI's Pre-Connect Conference is truly the most important global pharmaceutical event of the year.

In addition to the main conference, CPhI is also running 3 free to attend In-Focus Sessions across post-conference exhibition days providing hands-on, practical guidance on how to capitalise on the already established and up-and-coming industry sectors of Biopharmaceuticals, Animal Health and Natural Extracts.

The conference will include industry professionals from a range of organisations including Teva, Merck Serono, Novartis Pharma, Genentech, Ranbaxy, Boehringer Ingelheim, IMS Health, MHRA Biogen, BASF, Sanofi, Bayer and many more. With expert speakers from the international world of Pharma, this conference offers the opportunity to network and debate with the leaders in this field.

For full programme including a list of the expert speakers and to register please visit

About CPhI Conferences:

CPhI Conferences deliver the latest pharma market insight, in-depth case studies and exceptional networking opportunities through a programme of high-level conferences. The worldwide series of events, spanning four continents, provides the optimum forum for you to learn, make new business connections and identify the latest growth opportunities. Delivered by expert teams in each region, every conference is extensively researched with leading professionals, ensuring that CPhI Conferences tackle the most business critical issues facing the pharma industry today.


SOURCE CPhI Conferences
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CPhI & CPhI Pharma Evolution Add Stellar Names to Expert Industry Panel
2. Global Medical Devices Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry
3. US and European Computer Aided Detection (CAD) Industry
4. Global Dental Orthodontic Supplies Industry
5. Global Dental Restorative Supplies Industry
6. Virtify Launches Virtify SCM, A New Clinical Content Management Solution for the Life Science Industry
7. The First Comprehensive Remote Monitoring Solution For The Clinical Trial Industry
8. CPhI Opens Awards to Global Pharma Industry, Celebrating Tomorrows Innovations Today
9. Darryl Neil Penenberg, PhD. is recognized by Continental Whos Who as a Pinnacle Professional in the Pharmaceutical Industry
10. Society for Clinical Research Sites Receives Unprecedented Response from Industry Stakeholders to Support Sites by Joining Corporate Partnership Program
11. Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall
Post Your Comments:
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  Today, ... the launch of CareFront, a first-of-its-kind population health ... diagnosed with cancer. Designed to be built into ... cancer patients with resources for their care and ... program also offers tools to help patients understand ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... ... Growth in medical payments per workers’ compensation claim in Louisiana slowed from 2011 ... according to a recent study by the Workers Compensation Research Institute (WCRI). , ... per claim with more than seven days of lost time continued to be higher ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... technicians must mark the film for accurate interpretation by the radiologist. The marking ... an inventor from Sacramento, Calif., has found a way to alleviate this problem. ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):